Emerging Infections Program

The emergence and dissemination of carbapenem resistant Enterobacteriaceae and Pseudomonas aeruginosa in the US represents a serious threat to public health. Decreasing the impact of these organisms will require a coordinated effort among stakeholders including healthcare facilities and providers, public health, and industry. This report quantifies the magnitude of CRE and CRPA and the current recommended approach to control transmission of these organisms in healthcare facilities.

Group B Streptococcus (GBS) infection is a leading cause of neonatal sepsis in developed and developing countries around the world. GBS neonatal infection can be classified as either early-onset, which occurs within the first six days of life, or late-onset which occurs between 7–89 days of life.

This newsletter is released by the New Mexico Emerging Infections Program.

This newsletter is released by the New Mexico Emerging Infections Program.